Please login to bookmark Close

Lender RND Funding wants to revise its case against BDO Advisory and auditor Ernst & Young over advice given to defunct Adelaide company Gen1 Biotechnology, a week out from trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au